This is a great read from todays Age newspaper. Some interesting quotes given by various professionals that refer to the biotechnology that IMC are investing in. C-Diff mainly and the references to Monash University.
The Quote that got my attention was.....
"Jeremy Barr, now 34 and head of the Bacteriophage Biology Research Group in the School of Biological Sciences at Monash University, is not long back from a research visit to the Eliava Phage Therapy Centre in Georgia. “You could argue there is no better drug maker than nature,” says Barr, who has been awarded two research grants totalling $853,000, which he’s using to continue his scientific work on phages.
